Although neurodegenerative diseases in general, and Parkinson’s disease (PD) in particular, are triggered and/or exacerbated by neuroinflammatory mediators, an association between ICAM-1 and PD has not been adequately studied. This evidence concerns the gene ICAM1 and Parkinson disease.